✍ Scribed by Anthony R. Scialli
No coin nor oath required. For personal study only.
Compared to normal‐weight women, obese women have an increased risk of infertility and pregnancy complications. The most consistently described pregnancy complications are hypertensive disorders, gestational diabetes mellitus, thromboembolic events, and cesarean section. Fetal and neonatal complications may include congenital malformations, macrosomia, and shoulder dystocia. The literature suggests that women with a body mass index (BMI) ≥30 have approximately double the risk of having a child with a neural tube defect (NTD) compared to normal‐weight women, and the increased risk associated with higher maternal body weight does not appear to be modified by folic acid supplementation. The Public Affairs Committee of the Teratology Society supports the public health initiatives identified by the U.S. Food and Drug Administration in 2004 and the research initiatives identified by the National Institutes of Health in 2004. The Public Affairs Committee recommends that clinicians counsel women about appropriate caloric intake and exercise and that health‐care providers educate parents about appropriate childhood nutrition. Breast‐feeding should be encouraged based on evidence of a protective effect against childhood obesity, as well as other health advantages. Birth Defects Research (Part A), 2006. © 2006 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
September 12, 2007 marks the tenth anniversary of a public hearing that was hoped to be the death knell of the pregnancy labeling categories for pharmaceuticals, the A, B, C, D, X system of designations that was put in place by the US Food and Drug Administration (FDA) in 1979 (US FDA, 1979). The re
SUPPORTING EVIDENCE OF THE DEVELOPMENTAL TOXICITY OF ENDOCRINE DISRUPTORS ## Wildlife studies Considerable evidence for adverse effects of endocrinedisrupting chemicals has come from studies of wildlife This position paper was prepared by the authors at the request of the Public Affairs Committee